Clearside Biomedical Announces Third Patent Allowance In The U.S. Related To Proprietary Microneedle Drug Delivery Methods And Devices
1/29/2014 9:25:45 AM
ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, Inc., announces the U.S. Patent and Trademark Office (USPTO) granted U.S. Patent Application No. 13/453,407 as U.S. Patent No. 8,636,713 in a patent titled, "Methods and Devices for Drug Delivery to Ocular Tissue Using Microneedle." This is the third patent allowance in the U.S. related to its proprietary microneedle drug delivery methods and devices.
Help employers find you! Check out all the jobs and post your resume.
comments powered by